Home/Pipeline/Simdax (Levosimendan)

Simdax (Levosimendan)

Heart Failure

ApprovedCommercial

Key Facts

Indication

Heart Failure

Phase

Approved

Status

Commercial

Company

Orion Corporation

About Orion Corporation

Orion Corporation is a leading Nordic pharmaceutical company founded in 1917 and headquartered in Espoo, Finland. The company operates through three main business areas: proprietary products, specialty products, and fermion (contract manufacturing). Orion has a strong presence in neurology, oncology, and critical care, with established commercial operations across Europe and expanding global reach.

View full company profile

Therapeutic Areas

Oncology Neurology Critical Care Parkinson's Disease Sedation

Other Heart Failure Drugs

Drug	Company	Phase	Status
CNP analogue	Novo Nordisk	Phase 1	Active
Anti-miR-132 ASO	Novo Nordisk	Phase 2	Active
CK-136	Cytokinetics	Phase 1	Active
INPEFA (sotagliflozin)	Lexicon Pharmaceuticals	Approved	Commercial
NTP42	ATXA Therapeutics	Preclinical	Platform potential identified
Heart Failure Trial	Clinical Investigation Specialists	Not Specified	Actively Recruiting